CELZ
Price
$2.82
Change
-$0.17 (-5.69%)
Updated
Nov 13 closing price
Capitalization
7.25M
Intraday BUY SELL Signals
WVE
Price
$6.67
Change
-$0.28 (-4.03%)
Updated
Nov 13 closing price
Capitalization
1.12B
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CELZ vs WVE

Header iconCELZ vs WVE Comparison
Open Charts CELZ vs WVEBanner chart's image
Creative Medical Technology Holdings
Price$2.82
Change-$0.17 (-5.69%)
Volume$140.31K
Capitalization7.25M
Wave Life Sciences
Price$6.67
Change-$0.28 (-4.03%)
Volume$2.97M
Capitalization1.12B
CELZ vs WVE Comparison Chart in %
CELZ
Daily Signal:
Gain/Loss:
WVE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CELZ vs. WVE commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELZ is a Hold and WVE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CELZ: $2.82 vs. WVE: $6.67)
Brand notoriety: CELZ and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELZ: 153% vs. WVE: 110%
Market capitalization -- CELZ: $7.25M vs. WVE: $1.12B
CELZ [@Biotechnology] is valued at $7.25M. WVE’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELZ’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • CELZ’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, both CELZ and WVE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELZ’s TA Score shows that 3 TA indicator(s) are bullish while WVE’s TA Score has 4 bullish TA indicator(s).

  • CELZ’s TA Score: 3 bullish, 7 bearish.
  • WVE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, WVE is a better buy in the short-term than CELZ.

Price Growth

CELZ (@Biotechnology) experienced а -5.05% price change this week, while WVE (@Biotechnology) price change was -15.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

WVE is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.12B) has a higher market cap than CELZ($7.25M). CELZ YTD gains are higher at: 22.078 vs. WVE (-43.775). CELZ has higher annual earnings (EBITDA): -5.81M vs. WVE (-134.84M). WVE has more cash in the bank: 208M vs. CELZ (6.54M). CELZ has less debt than WVE: CELZ (2.74M) vs WVE (21.7M). WVE has higher revenues than CELZ: WVE (93.9M) vs CELZ (6K).
CELZWVECELZ / WVE
Capitalization7.25M1.12B1%
EBITDA-5.81M-134.84M4%
Gain YTD22.078-43.775-50%
P/E RatioN/AN/A-
Revenue6K93.9M0%
Total Cash6.54M208M3%
Total Debt2.74M21.7M13%
FUNDAMENTALS RATINGS
CELZ vs WVE: Fundamental Ratings
CELZ
WVE
OUTLOOK RATING
1..100
8177
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
50100
SEASONALITY SCORE
1..100
5032

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (50) in the Biotechnology industry is in the same range as CELZ (76) in the null industry. This means that WVE’s stock grew similarly to CELZ’s over the last 12 months.

WVE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CELZ (100) in the null industry. This means that WVE’s stock grew similarly to CELZ’s over the last 12 months.

CELZ's SMR Rating (98) in the null industry is in the same range as WVE (99) in the Biotechnology industry. This means that CELZ’s stock grew similarly to WVE’s over the last 12 months.

CELZ's Price Growth Rating (52) in the null industry is in the same range as WVE (64) in the Biotechnology industry. This means that CELZ’s stock grew similarly to WVE’s over the last 12 months.

CELZ's P/E Growth Rating (50) in the null industry is somewhat better than the same rating for WVE (100) in the Biotechnology industry. This means that CELZ’s stock grew somewhat faster than WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELZWVE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CELZ
Daily Signal:
Gain/Loss:
WVE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNR106.75-1.93
-1.78%
Pentair plc
FSM8.40-0.23
-2.67%
Fortuna Mining Corp
MITQ0.69-0.03
-4.35%
Moving iMage Technologies
IVA3.82-0.23
-5.68%
Inventiva SA
GAIA4.05-0.31
-7.11%
Gaia

CELZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELZ has been loosely correlated with LABFF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CELZ jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELZ
1D Price
Change %
CELZ100%
-5.69%
LABFF - CELZ
35%
Loosely correlated
N/A
RARE - CELZ
34%
Loosely correlated
-1.88%
MREO - CELZ
33%
Poorly correlated
-3.26%
EDIT - CELZ
31%
Poorly correlated
-5.93%
WVE - CELZ
30%
Poorly correlated
-4.10%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with XNCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-4.20%
XNCR - WVE
51%
Loosely correlated
-3.23%
SYRE - WVE
50%
Loosely correlated
+0.34%
NRIX - WVE
50%
Loosely correlated
-5.37%
NUVL - WVE
50%
Loosely correlated
+0.91%
XENE - WVE
49%
Loosely correlated
-0.60%
More